BD Announces Flu Product Order from U.S. Government
September 3, 2009
Syringes, needles, sharps containers and alcohol swabs purchased for use in novel H1N1 flu virus immunization campaign FRANKLIN LAKES, N.J.-- BD (Becton, Dickinson and Company) (NYSE: BDX - News) announced today that it has received a significant order from the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Department of Health and Human [...]
Helicos BioSciences Provides Q2 2009 Operating Highlights and Strategic Update
September 3, 2009
Achieves Significant Commercial and Technical Milestones - Engages Thomas Weisel Partners to Advise on Strategic Alternatives CAMBRIDGE, Mass.--Helicos BioSciences Corporation (NASDAQ: HLCS) announced today its operating highlights for the quarter ended June 30, 2009 and other recent developments following the filing of its Quarterly Report on Form 10-Q for the period ended June 30, 2009. [...]
Luminex Receives 510(K) Clearance for New Cystic Fibrosis Test
September 3, 2009
New Diagnostic Test Offers Fast, Accurate Detection of 39 Cystic Fibrosis Gene Mutations - Will Be Used in Screening Potential Parents and to Assist in Screening Newborns for Genetic Disease AUSTIN, Texas--Luminex Corporation (NASDAQ: LMNX - News), the worldwide leader in multiplexed solutions, today announced that it has received 510(k) clearance from the U.S. Food [...]
Thermo Fisher Scientific Introduces Four New Industry Specific Analytical Packages
September 3, 2009
Thermo Fisher Scientific Introduces Four New Industry Specific Analytical Packages for Fast, Accurate and Reliable X-ray Analysis ECUBLENS, Switzerland - Thermo Fisher Scientific Inc., the world leader in serving science, today announced the introduction of four new analytical packages designed to enhance industry specific routine X-ray analysis. The packages are based on the successful Thermo [...]
Beckman Coulter and Propel Labs Enter into Collaboration for Flow Cytometry
September 3, 2009
Propel to Support Beckman Coulter with Field Upgrades of MoFlo™ Instruments ORANGE COUNTY, Calif. - Beckman Coulter, Inc. and Propel Labs, LLC, have entered into a new strategic alliance for flow cytometry. As part of this alliance, Propel will support Beckman Coulter with field upgrades of MoFlo instruments to the specifications associated with the more [...]
B·R·A·H·M·S and Thermo Fisher Scientific join forces
September 3, 2009
B·R·A·H·M·S and Thermo Fisher Scientific join forces to create a leader in specialty diagnostics Hennigsdorf, B·R·A·H·M·S, a leading diagnostics company, and Thermo Fisher Scientific, the world leader in serving science, join forces to establish a European Center of Excellence for clinical diagnostics with a focus on innovative biomarkers. B·R·A·H·M·S announces the signature of a Share [...]
Covidien Announces Reporting Changes
September 3, 2009
DUBLIN--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced several financial reporting changes. The Specialty Chemicals business, previously reported in discontinued operations, has been reclassified to continuing operations within the Pharmaceuticals segment as a result of the Company’s decision to cease marketing the business for sale. The reclassification of this business to [...]
QIAGEN Launches Innovative Blood Dry Storage Products
September 2, 2009
QIAsafe® DNA Blood Tubes and Plates offer high DNA yield, easy transport and storage at room temperature Venlo, The Netherlands - Biobanks are the intermediary between donors and research labs to ensure the safe effective transfer of the biological information held in samples. The number of biobanks is increasing, as is the cost for power [...]
Agilent Technologies Separates Bio-Analytical Business Into Two Businesses
September 2, 2009
Agilent Technologies Separates Bio-Analytical Business Into Life Sciences and Chemical Analysis Groups - Organizational Change Fueled by Growth in Bio-Analytical Measurement SANTA CLARA, Calif.--Agilent Technologies Inc. (NYSE:A) has announced the separation of its Life Science and Chemical Analysis Group into two businesses, Chemical Analysis and Life Sciences. The change in structure reflects the growth opportunities [...]
MDS Announces Strategic Repositioning
September 2, 2009
Company Signs Agreement to Sell MDS Analytical Technologies to Danaher Corporation; Plans Substantial Return of Sale Proceeds to Shareholders; Announces Intent to Sell MDS Pharma Services TORONTO, Sept. 2 - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today announced that it has entered [...]

